Companies / BOC Sciences / Futuximab
BOC Sciences

Futuximab | BOC Sciences

Futuximab is a chimeric monoclonal antibody directed against EGFR. Futuximab has been used in the research of cancer therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.